Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
2000 1
2005 2
2006 6
2007 6
2008 4
2009 6
2010 6
2011 7
2012 6
2013 14
2014 13
2015 12
2016 14
2017 9
2018 8
2019 13
2020 10
2021 10
2022 7
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Symptomatic Vasospasm after Surgical Clipping and Endovascular Coiling.
Imamura H, Tani S, Adachi H, Fukumitsu R, Sunohara T, Fukui N, Omura Y, Sasaki N, Akiyama T, Fukuda T, Kajiura S, Shigeyasu M, Asakura K, Horii R, Sakai N. Imamura H, et al. Among authors: horii r. Neurol Med Chir (Tokyo). 2022 May 15;62(5):223-230. doi: 10.2176/jns-nmc.2021-0126. Epub 2022 Apr 12. Neurol Med Chir (Tokyo). 2022. PMID: 35418528 Free PMC article.
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.
Hattori M, Honma N, Nagai S, Narui K, Shigechi T, Ozaki Y, Yoshida M, Sakatani T, Sasaki E, Tanabe Y, Tsurutani J, Takano T, Saji S, Masuda S, Horii R, Tsuda H, Yamaguchi R, Toyama T, Yamauchi C, Toi M, Yamamoto Y. Hattori M, et al. Among authors: horii r. Breast Cancer. 2024 May;31(3):335-339. doi: 10.1007/s12282-024-01550-0. Epub 2024 Mar 4. Breast Cancer. 2024. PMID: 38433181 Free PMC article.
First-in-human trial of Stabilizer device in neuroendovascular therapy.
Sakai C, Sakai N, Takayanagi A, Imamura H, Ohta T, Koyanagi M, Goto M, Fukumitsu R, Sunohara T, Fukui N, Matsumoto S, Akiyama T, Takano Y, Haruyama H, Go K, Kajiura S, Shigeyasu M, Asakura K, Horii R, Naramoto Y, Nishii R, Yamamoto Y, Teranishi K, Kawade S, Imahori T, Kaneko N, Tateshima S. Sakai C, et al. Among authors: horii r. Heliyon. 2023 Mar 11;9(3):e14360. doi: 10.1016/j.heliyon.2023.e14360. eCollection 2023 Mar. Heliyon. 2023. PMID: 36950603 Free PMC article.
131 results